Hay Ian D, Hutchinson Maeve E, Gonzalez-Losada Tomas, McIver Bryan, Reinalda Megan E, Grant Clive S, Thompson Geoffrey B, Sebo Thomas J, Goellner John R
Division of Endocrinology and Internal Medicine, Mayo Clinic and College of Medicine, Rochester, Minn, USA.
Surgery. 2008 Dec;144(6):980-7; discussion 987-8. doi: 10.1016/j.surg.2008.08.035.
The study aims were to characterize patients with papillary thyroid microcarcinoma (PTM) and to describe post-surgical outcome.
Nine hundred PTM patients had initial treatment at Mayo Clinic during 1945-2004. Mean follow-up was 17.2 years. Recurrence and mortality details were derived from a computerized database.
Median tumor size was 7 mm; 98% were intrathyroidal. 273 patients (30%) had neck nodal involvement; 3 (0.3%) had distant metastases at diagnosis. Seven-hundred and sixty-five (85%) underwent bilateral lobar resection (BLR; total-, near-total, or bilateral subtotal thyroidectomy). Regional nodes were removed by either "node picking" (27%) or compartmental dissection (23%). Tumor resection was incomplete in 5 (0.6%). Radioiodine remnant ablation (RRA) was performed in 155 (17%). Overall survival did not differ from expected for an age and gender matched control group (P = .96); 3 patients (0.3%) died of PTM. None of the 892 patients with initial complete tumor resection developed metastatic spread during 20 postoperative years. Twenty-year and 40-year tumor recurrence rates were 6% and 8%, respectively. Higher recurrence rates were seen with multifocal tumors (P = .004) and node-positive patients (P < .001). Neither more extensive surgery nor RRA reduced recurrence rates compared to unilateral lobectomy.
More than 99% of PTM patients are not at risk of distant spread or cancer mortality. RRA after BLR did not improve postoperative outcome.
本研究旨在对甲状腺微小乳头状癌(PTM)患者进行特征描述,并阐述术后结局。
900例PTM患者于1945年至2004年在梅奥诊所接受初始治疗。平均随访时间为17.2年。复发和死亡细节来自计算机化数据库。
肿瘤大小中位数为7mm;98%位于甲状腺内。273例患者(30%)有颈部淋巴结受累;3例(0.3%)在诊断时发生远处转移。765例(85%)接受了双侧叶切除术(BLR;全甲状腺切除、近全甲状腺切除或双侧次全甲状腺切除)。区域淋巴结通过“摘除法”(27%)或分区清扫术(23%)切除。5例(0.6%)肿瘤切除不完全。155例(17%)进行了放射性碘残留消融(RRA)。总体生存率与年龄和性别匹配的对照组预期无差异(P = 0.96);3例患者(0.3%)死于PTM。892例初始肿瘤完全切除的患者在术后20年内均未发生转移扩散。20年和40年的肿瘤复发率分别为6%和8%。多灶性肿瘤(P = 0.004)和淋巴结阳性患者(P < 0.001)的复发率较高。与单侧叶切除术相比,更广泛的手术和RRA均未降低复发率。
超过99%的PTM患者不存在远处扩散或癌症死亡风险。BLR后进行RRA并未改善术后结局。